What Happened
In January 2025, Dr. Kamal Kabakibou and his practice, The Center for Pain Management, settled False Claims Act and Controlled Substances Act claims in the Northern District of Georgia. The government alleged that he performed unnecessary laboratory testing and, when travelling abroad, pre-signed prescriptions for nurse practitioners to dispense, many for Schedule II opioids. The defendants agreed to pay $3.5 million jointly and to submit regular monitoring reports to the DEA for five years. They also entered a three-year integrity agreement with HHS-OIG. The claims were allegations only, with no determination of liability.
“he pre-signed prescriptions and left them for his nurse practitioners to dispense”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.